University Hospital, Caen

This study tested a combination of two cancer drugs, ixazomib and daratumumab, without using steroids (dexamethasone) in patients aged 65 and older whose multiple myeloma had returned after prior treatment. The goal was to see if this approach could effectively control the diseas…

This study tested whether adding anakinra (a drug that blocks inflammation) to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a disease that causes swollen arteries. About 30 adults aged 50 and older were enrolled, but the trial was stop…